Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

InnoSIGN

InnoSIGN is a manufacturer of precision medicine for diagnostics and drug development applications.
2020
11-50
Eindhoven, Noord-Brabant, The Netherlands
BiotechnologynologyLife ScienceMedicalPrecision Medicine

Investment Funding

Last Funding Stage

Series A

Total Funding Amount

8.08M

Last Funding Amount

8.08M

Last Funding Date

22-03-2022

Startup Stage

Early Stage

Lead Investors

Thuja Capital, Casdin Capital, Life Science Angels, Brabant Development

Revenue

$1M to $10M